ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
| Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
| Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
| Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
| Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
| Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |